Bilevel positive airway pressure (BPAP) for moderate-to-severe pediatric asthma exacerbations: A randomized, controlled trial (BPAP)

← Back to all studies

Bilevel positive airway pressure (BPAP) for moderate-to-severe pediatric asthma exacerbations: A randomized, controlled trial (BPAP)

Health Condition: Asthma
Health Impact Domain: -

Summary

The goal is to perform a multi-centered clinical trial to determine if early, ED initiation of BPAP is effective and safe in children with acute moderate-to-severe asthma exacerbations. Before conducting a definitive trial, we need to first carry out an R34 feasibility study.

Key Publications

-

Related Media

-

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.